In a study of mouse adenomyosis, EGCG emerged as a promising treatment strategy that suppressed myometrial infiltration, improved generalized hyperalgesia, and reduced uterine contractility, while elevating the expression of the progesterone receptor [34,35]. Here, PGR is linked to adenomyosis.